Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Galmed Pharmaceuticals Debt to Equity Ratio 2013-2025 | GLMD

Current and historical debt to equity ratio values for Galmed Pharmaceuticals (GLMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Galmed Pharmaceuticals debt/equity for the three months ending June 30, 2025 was 0.00.
Galmed Pharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-06-30 $0.00B $0.02B 0.12
2025-03-31 $0.00B $0.02B 0.11
2024-12-31 $0.00B $0.02B 0.13
2024-09-30 $0.00B $0.02B 0.14
2024-06-30 $0.00B $0.01B 0.13
2024-03-31 $0.00B $0.01B 0.14
2023-12-31 $0.00B $0.01B 0.20
2023-09-30 $0.00B $0.02B 0.14
2023-06-30 $0.00B $0.01B 0.26
2023-03-31 $0.00B $0.01B 0.23
2022-12-31 $0.00B $0.01B 0.23
2022-09-30 $0.01B $0.02B 0.33
2022-06-30 $0.00B $0.02B 0.14
2022-03-31 $0.01B $0.02B 0.24
2021-12-31 $0.01B $0.03B 0.20
2021-09-30 $0.01B $0.04B 0.18
2021-06-30 $0.01B $0.05B 0.16
2021-03-31 $0.01B $0.05B 0.14
2020-12-31 $0.01B $0.04B 0.19
2020-09-30 $0.01B $0.05B 0.12
2020-06-30 $0.01B $0.06B 0.08
2020-03-31 $0.01B $0.06B 0.10
2019-12-31 $0.01B $0.07B 0.10
2019-09-30 $0.00B $0.08B 0.05
2019-06-30 $0.00B $0.08B 0.05
2019-03-31 $0.00B $0.09B 0.03
2018-12-31 $0.00B $0.09B 0.03
2018-09-30 $0.00B $0.09B 0.02
2018-06-30 $0.00B $0.09B 0.04
2018-03-31 $0.00B $0.01B 0.20
2017-12-31 $0.00B $0.02B 0.24
2017-09-30 $0.00B $0.01B 0.48
2017-06-30 $0.00B $0.01B 0.61
2017-03-31 $0.00B $0.01B 0.53
2016-12-31 $0.01B $0.01B 0.49
2016-09-30 $0.00B $0.02B 0.25
2016-06-30 $0.00B $0.01B 0.25
2016-03-31 $0.00B $0.02B 0.18
2015-12-31 $0.00B $0.02B 0.13
2015-09-30 $0.00B $0.03B 0.06
2015-06-30 $0.00B $0.03B 0.06
2015-03-31 $0.00B $0.03B 0.05
2014-12-31 $0.00B $0.03B 0.05
2014-09-30 $0.00B $0.03B 0.09
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B $0.04B 0.05
2013-12-31 $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B -1.39
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.000B
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.531B 30.59
Zoetis (ZTS) United States $52.936B 18.95
Takeda Pharmaceutical (TAK) Japan $44.579B 9.10
Daiichi Sankyo, - (DSNKY) Japan $41.884B 20.86
BeOne Medicines - (ONC) Switzerland $37.686B 199.80
Sandoz Group AG (SDZNY) Switzerland $30.065B 0.00
United Therapeutics (UTHR) United States $19.772B 17.40
Merck (MKKGY) Germany $16.918B 11.00
Summit Therapeutics (SMMT) United States $14.775B 0.00
Neurocrine Biosciences (NBIX) United States $14.686B 35.24
Shionogi (SGIOY) Japan $14.581B 13.39
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.298B 0.00
Ionis Pharmaceuticals (IONS) United States $11.735B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Corcept Therapeutics (CORT) United States $8.311B 89.78
Eisai (ESAIY) $8.236B 0.00
Stevanato Group S.p.A (STVN) Italy $7.320B 40.97
Grifols, S.A (GRFS) Spain $6.002B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.493B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.075B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.753B 17.84
Hypermarcas (HYPMY) Brazil $3.123B 23.48
Centessa Pharmaceuticals (CNTA) United Kingdom $3.018B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.839B 9.06
Dyne Therapeutics (DYN) United States $2.809B 0.00
Soleno Therapeutics (SLNO) United States $2.616B 0.00
Ocular Therapeutix (OCUL) United States $2.390B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.067B 24.50
Guardian Pharmacy Services (GRDN) United States $1.979B 38.11
Avadel Pharmaceuticals (AVDL) Ireland $1.828B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.522B 90.38
Ardelyx (ARDX) United States $1.489B 0.00
Harrow (HROW) United States $1.435B 88.04
Collegium Pharmaceutical (COLL) United States $1.417B 7.02
Amylyx Pharmaceuticals (AMLX) United States $1.393B 0.00
Xeris Biopharma Holdings (XERS) United States $1.234B 0.00
Nektar Therapeutics (NKTR) United States $1.205B 0.00
Oruka Therapeutics (ORKA) United States $1.171B 0.00
Enliven Therapeutics (ELVN) United States $1.163B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Xencor (XNCR) United States $1.062B 0.00
Evotec AG (EVO) Germany $1.055B 0.00
Cronos Group (CRON) Canada $0.965B 0.00
Theravance Biopharma (TBPH) United States $0.932B 39.36
ARS Pharmaceuticals (SPRY) United States $0.867B 0.00
Organogenesis (ORGO) United States $0.825B 0.00
ProKidney (PROK) United States $0.824B 0.00
Savara (SVRA) United States $0.748B 0.00
Esperion Therapeutics (ESPR) United States $0.741B 0.00
Aquestive Therapeutics (AQST) United States $0.694B 0.00
Elite Pharmaceuticals (ELTP) United States $0.694B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.689B 6.15
Bioventus (BVS) United States $0.637B 13.05
4D Molecular Therapeutics (FDMT) United States $0.617B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
Zevra Therapeutics (ZVRA) United States $0.531B 0.00
Lexeo Therapeutics (LXEO) United States $0.492B 0.00
Akebia Therapeutics (AKBA) United States $0.480B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.469B 11.11
Siga Technologies (SIGA) United States $0.450B 6.17
Altimmune (ALT) United States $0.447B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
Nature's Sunshine Products (NATR) United States $0.350B 20.83
USANA Health Sciences (USNA) United States $0.348B 9.70
Lyell Immunopharma (LYEL) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Korro Bio (KRRO) United States $0.308B 0.00
Larimar Therapeutics (LRMR) United States $0.300B 0.00
Pyxis Oncology (PYXS) United States $0.285B 0.00
Achieve Life Sciences (ACHV) Canada $0.254B 0.00
Aclaris Therapeutics (ACRS) United States $0.249B 0.00
Journey Medical (DERM) United States $0.238B 0.00
OmniAb (OABI) United States $0.232B 0.00
Heron Therapeutics (HRTX) United States $0.213B 0.00
AleAnna (ANNA) United States $0.210B 0.00
Protara Therapeutics (TARA) United States $0.207B 0.00
MediWound (MDWD) Israel $0.205B 0.00
Avalo Therapeutics (AVTX) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.161B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.154B 0.00
Cassava Sciences (SAVA) United States $0.150B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.125B 0.00
Inhibikase Therapeutics (IKT) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Context Therapeutics (CNTX) United States $0.109B 0.00
Relmada Therapeutics (RLMD) United States $0.109B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Gain Therapeutics (GANX) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 35.00
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
Assertio Holdings (ASRT) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.087B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.085B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Plus Therapeutics (PSTV) United States $0.078B 0.00
Prelude Therapeutics (PRLD) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
BioNxt Solutions (BNXTF) Canada $0.063B 0.00
Talphera (TLPH) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Arch Biopartners (ACHFF) Canada $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
FibroGen (FGEN) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 25.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Vyome Holdings (HIND) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Heatwurx (PCSA) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.013B 0.02
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.85
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00